Thats exactly why we launched the GLP-1 Supply Tracker
Trial populations and endpoints vary, and individual outcomes differ
Common experiences during weeks 1-2 include mild nausea (reported by approximately 14% of participants at the 1 mg dose level), slight changes in appetite timing, increased awareness of fullness cues, and occasional fatigue as the body processes a new metabolic signal
Lifestyle adjustments Combining Wegovy with a balanced, reduced calore diet can enhance weight loss
(Present-day weight-loss drugs work on just one or two hunger-related hormones.) One particular triple agonist, called retatrutide, has recently been shown in clinical trials to help people with severe obesity shed almost 30 percent of their body weight after about 48 weeks
However, not everyone experiences immediate or consistent weight loss while on these medications, which can be perplexing and frustrating